{"cursor":"9697","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n| verifiedrevid = 460956607 IUPAC_name = N-[(5aR,6aS,7S,9Z,10aS)-9-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-\n| 1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-\n| decahydrotetracen-2-yl]-2-(tert-butylamino)acetamide image = Tigecycline\n| structure.svg width = 350\n\n\n| tradename = Tygacil Drugs.com = pregnancy_AU = D pregnancy_US = D legal_AU =\n| S4 legal_US = Rx-only routes_of_administration = IV only\n\n\n| bioavailability = NA protein_bound = 71-89% metabolism = not metabolised elimination_half-\n| life = 42.4 hours excretion = 59% biliary, 33% renal\n\n\n| CASNo_Ref = CAS_number_Ref = CAS_number = 220620-09-7 ATC_prefix = J01\n| ATC_suffix = AA12 PubChem = 5282044 DrugBank_Ref = DrugBank = DB00560\n| ChemSpiderID_Ref = ChemSpiderID = 10482314 UNII_Ref = UNII = 70JE2N95KR\n| KEGG_Ref = KEGG = D01079 ChEBI_Ref = ChEBI = 149836 ChEMBL_Ref = ChEMBL\n| = 376140\n\n\n| C=29 | H=39 | N=5 | O=8 molecular_weight = 585.65 g/mol smiles = CC(C)(C)NCC(-\n| =O)Nc1cc(c2C[C@H]3C[C@H]4[C@H](N(C)C)C(\\O)=C(\\C(N)=O)C(=O)[C@@]4(O)C(/O)=C3/C-\n| (=O)c2c1O)N(C)C InChI = 1/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-\n| 21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h-\n| 10,12,14,21,31,36,38-39,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-\n| ,29-/m0/s1 InChIKey = FPZLLRFZJZRHSY-HJYUBDRYBF StdInChI_Ref = StdInChI = 1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-\n| 21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h-\n| 10,12,14,21,31,36,38-39,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-\n| ,29-/m0/s1 StdInChIKey_Ref = StdInChIKey = FPZLLRFZJZRHSY-HJYUBDRYSA-N\n| synonyms = N-[(5aR,6aS,7S,9Z,10aS)-9-(amino-hydroxy-methylidene)-4,7-\n| bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-\n| tetracen-2-yl]-2-(tert-butylamino)acetamide\n}}\n\n'Tigecycline' (INN) () is a glycylcycline antibiotic\ndeveloped by Francis Tally {{Cite journal |last=Projan |first=Steven J\n|authorlink= |year=2010|month=Jan. |title=Francis Tally and the discovery and\ndevelopment of tigecycline: a personal reminiscence |journal=Clin. Infect. Dis.\n|volume=50 Suppl 1 |issue= |pages=S24â5 |publisher= |location = United States|\nissn = | pmid = 20067389 |doi = 10.1086/647941\n| bibcode = | oclc =| id = | url = | DUPLICATE DATA: doi = 10.1086/647941 |\n| language = | format = | accessdate = | laysummary = | laysource = | laydate =\n| | quote =\n }} and marketed by Wyeth under the brand name 'Tygacil'. It was given a\n U.S. Food and Drug Administration (FDA) fast-track approval and was approved on\n June 17, 2005. It was developed in response to the growing prevalence of\n antibiotic resistance in bacteria such as [[Staphylococcus aureus]] and\n [[Acinetobacter baumannii]]. The New Delhi metallo-Î²-Lactamase multidrug-\n resistant Enterobacteriaceae has also shown susceptibility to tigecycline.\n","linknr":374,"url":"Tigecycline","recorded":1362500976,"links":29,"instances":[],"pdf":[],"categories":["Glycylcycline antibiotics","Amides"],"headings":["Structure","Mechanism of action","Indications","Dosing","Side effects","Other uses","Synonyms","References","External links"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/1/14/Tigecycline_structure.svg/350px-Tigecycline_structure.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png","//bits.wikimedia.org/static-1.21wmf10/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.21wmf10/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Kidney","International_Nonproprietary_Name","Glycylcycline","Antibiotic","Francis_Tally","Clin._Infect._Dis.","United_States","Wyeth","Food_and_Drug_Administration","Antibiotic_resistance","New_Delhi_metallo-β-Lactamase","Glycylcyclines","Tetracycline","Derivative","Minocycline","Bacteriostatic","Protein_synthesis_inhibitor","30S_ribosomal_subunit","Aminoacyl-tRNA","Prokaryotic_translation","Vancomycin","Aztreonam","Complicated_skin_and_skin_structure_infection","Imipenem","Complicated_intra-abdominal_infection","Gram-positive","Gram-negative","Methicillin-resistant_Staphylococcus_aureus","Acinetobacter_baumannii","Adverse_effect","Tetracycline","Acute_myeloid_leukaemia"]}